TRU Aseptics Receives SQF Level 2 8.0 Certification

TRU Aseptics, an aseptic contract manufacturer, announced today it has earned SQF Level 2 8.0 Certification.

BELOIT, WI, UNITED STATES, July 17, 2018 /EINPresswire.com/ — TRU Aseptics ("TRU"), a low and high acid aseptic contract manufacturer, announced today it has earned SQF Level 2 8.0 Certification from the Safe Quality Food (SQF) Institute which is recognized by the Global Food Safety Initiative (GFSI). The SQF certification means that TRU has successfully passed a rigorous food safety auditing process and certifies that its manufacturing facility and warehouse are compliant with HACCP food safety regulations.

"Gaining SQF Level 2 8.0 certification is a significant accomplishment for TRU as a company," said Stacey Huels, Chairman of TRU Aseptics. "We believe food safety is of utmost importance, so investing the time and resources needed to achieve SQF certification was vital to us. It verifies to clients that we are committed to following stringent food safety programs."

The Safe Quality Food Institute's Mission is "To deliver consistent, globally recognized food safety and quality certification programs based on sound scientific principles, consistently applied across all industry sectors, and valued by all stakeholders."

About TRU Aseptics
TRU Aseptics is a privately-held low and high acid aseptic contract manufacturer located in Beloit, WI. Built on the TRU TO NATURE™ approach, our mission is to produce food and beverage ingredients that promote life, health and well-being. TRU is also a certified Grade "A" Dairy Manufacturer and Interstate Milk Shipper. TRU provides liquid aseptic solutions to the FoodService, C-store, Club Store and Industrial markets. We focus on Bag in Box and Bulk processing and packing of dairy, plant-based, coffees, teas, vegetable and fruit juices. Additionally, TRU offers compounding, unitized packaging and standardization of products with quality variances.

For More Information: Contact Jennifer Stout: stout@truaseptics.com
630-590-5375
www.TRUaseptics.com
###

Jennifer Stout
TRU Aseptics
630-590-5375
email us here


Source: EIN Presswire

Intermountain Healthcare Donates 6,000 Books to Utah Children

SALT LAKE CITY, UTAH, USA, July 17, 2018 /EINPresswire.com/ — Intermountain Healthcare is donating 6,000 books to at-risk children. The donation supports organizations in Utah dedicated to childhood literacy and development, including the Salt Lake County Health Department and the Reach Out and Read program.

“Community organizations will receive books, as will our pediatric clinics and newborn intensive care units, so we can encourage reading to children right from the beginning,” said Mikelle Moore, Intermountain senior vice president of Community Health.

Intermountain’s Community Giving program provided funding for nearly four thousand books, while Intermountain leaders from across the system contributed an additional 2,100 books. Donations included familiar titles such as The Very Hungry Caterpillar, Goodnight Moon, and Where the Wild Things Are. Nearly 30 percent of all donated titles were printed in languages other than English.

The Salt Lake County Health Department received books in support of their home visitation programs. “We provide approximately 4,500 visits per year,” said Kami Peterson, assistant division director of Family Health. “A lot of the families that we visit…in Salt Lake County are low-income families and don’t have access to books. Being able to give them a book and talk about literacy is really important.”

Caroline Moreno, education program manager with Salt Lake County Human Services, was optimistic about the impact the donation will have on the community. “Reading to a kid when they’re just born, when they’re five years old, when they’re 10 years old, is super important for brain development,” she said.

The research agrees with her. A 2016 study found that 3-year-olds whose parents read to them from an early age were significantly less likely to be aggressive or hyperactive. Follow up research determined the positive effects persisted as those children were entering kindergarten. Children whose families continued to read to them were less likely to have behavioral problems or experience trouble with concentration, key indicators of success in school.

Reach Out and Read, a nonprofit organization that incorporates books into pediatric care, will also receive supplies. The organization’s 34 Utah locations, roughly half of which operate out of Intermountain clinics, serve about 41,000 children annually.

Intermountain Healthcare is a Utah-based not-for-profit system of 22 hospitals, 170 clinics, a Medical Group with about 2,300 employed physicians and advanced practice clinicians, a health plans group called SelectHealth, and other medical services. Intermountain is widely recognized as a leader in transforming healthcare through high quality and sustainable costs. For more information about Intermountain, visit www.intermountainhealthcare.org.

Daron Cowley
Intermountain Healthcare
801-442-2834
email us here


Source: EIN Presswire

DMA Tech Solutions Partners with PCIHIPAA to Help Clients Navigate HIPAA Compliance Regulations

DMA Tech Solutions and PCIHIPAA - HIPAA Compliance

The partnership will provide DMA practices a comprehensive compliance program that helps them save time and money navigating stringent HIPAA requirements.

Now, it is more important than ever for DMA to take a leadership role in helping our clients make patient data privacy and security a top priority.”

— Jeff Suglio, President DMA Tech Solutions

RICHFIELD, OHIO, UNITED STATES, July 17, 2018 /EINPresswire.com/ — DMA Tech Solutions (DMA) announced today its partnership with PCIHIPAA, a leading Payments Card Industry (PCI) and HIPAA compliance provider. The partnership is focused on protecting DMA clients from the onslaught of ransomware attacks, HIPAA violations, and data breaches impacting medical and dental practices throughout the United States. Under HIPAA’s Security and Privacy Rules, healthcare providers are required to take proactive steps to protect sensitive patient information. The partnership comes on the heels of an important announcement surrounding HIPAA compliance regulation. The Director of the U.S. Department of Health and Human Services’ Office for Civil Rights recently stated, "Just because you are a small medical or dental practice doesn't mean we're not looking and that you are safe if you are violating the law. You won't be." In addition, according to the HHS website, just recently a Ohio healthcare provider had 42,625 patient records stolen. Protected Health Information (PHI) continues to be under attack as hackers strive to monetize the stolen data on the dark web.



“DMA Tech Solutions has been providing state – of- the – art IT solutions to healthcare providers for years. Now, it is more important than ever for DMA to take a leadership role in helping our clients make patient data privacy and security a top priority. We vetted many HIPAA compliance providers and believe PCIHIPAA’s OfficeSafe Compliance Program is the right solution for our clients. Our partnership adds another layer of protection for our clients. It's easy to implement and I'm confident our clients will experience savings, convenience and peace of mind." said Jeff Suglio, President, DMA Tech Solutions.

According to the U.S. Department of Health and Human Services, OCR has received over 150,000 HIPAA complaints following the issuance of the Privacy Rule in April 2003. A rising number of claims filed under HIPAA in recent years have led many patients to question whether or not their personal payment and health information is safe. As the government has become more aggressive in HIPAA enforcement, large settlements have become widespread and rising penalties for HIPAA non-compliance are a reality.

 According to HHS.gov, the types of HIPAA violations most often identified are:


1) Impermissible uses and disclosures of protected health information (PHI)

2) Lack of technology safeguards of PHI

3) Lack of adequate contingency planning in case of a data breach or ransomware attack

4) Lack of administrative safeguards of PHI

5) Lack of a mandatory HIPAA risk assessment

6) Lack of executed Business Associate Agreements

7) Lack of employee training and updated policies and procedures

“We are excited to be working with Jeff, Sam and everyone at DMA Tech Solutions. They have a proud history of providing IT solutions for growing practices. If Equifax can get breached so can a healthcare provider. We find that many practices don't have the resources to navigate HIPAA law, and are unaware of common vulnerabilities. We're excited to add the OfficeSafe Compliance Program to DMA's extensive suite of services. We invite every member to conduct a complimentary Self-Assessment to quickly identity key vulnerabilities in their practice.” said Jeff Broudy, CEO of PCIHIPAA.

##

DMA Tech Solutions
DMA understands the need for a comprehensive approach. They employ a team of dedicated, highly skilled IT professionals that work with healthcare providers to determine specific needs, and then incorporate the latest technology into an integrated system that accommodates future growth. They also provide continued project management to ensure optimum digital operations and integration within all types of practices.

About PCIHIPAA
PCIHIPAA is an industry leader in PCI and HIPAA compliance by providing turnkey, convenient solutions for its clients. Its OfficeSafe Compliance Program is "award winning" and takes the guesswork out of compliance while providing the assurance and insurance healthcare providers need to protect their future. PCIHIPAA was recently voted one of the Top 10 Healthcare Compliance Company's of 2017. Learn more at OfficeSafe.com and PCIHIPAA.com

Jeff Broudy
PCIHIPAA
8185198597
email us here


Source: EIN Presswire

ANOTHER FIRST FOR EPICAN

EPICAN Bud Tenders await customers on 1st day of opening

Brothers Dwayne McKenzie, President and Karibe Mckenzie, CEO of EPICAN cut the ribbon at official store opening in Kingston, Jamaica

Kingston’s 1st Cannabis Store Opens its doors

Our long-term national strategic interest is to ensure the competitiveness of Jamaica’s marijuana industry”

— Karibe McKenzie, CEO EPICAN

KINGSTON, JAMAICA, July 17, 2018 /EINPresswire.com/ — ANOTHER FIRST FOR EPICAN

KIngston’s 1st Cannabis Store Opens its doors

They say where there’s smoke there’s fire! Last night Epican (Epic Cannabis), the first seed-to-sale cannabis retail store proved that when it opened its doors at Marketplace in Kingston, blazing a trail for over 300 curious cannabis enthusiasts in attendance. Concert performances from Jesse Royal, Bugle, Tosh, Queen Ifrica & Tony Rebel kicked off this momentous event in grand style. Spirits were high thanks to Gabre, the much-loved Dub Club DJ, with Maroon drummers from Accompong igniting hearts and souls with their hypnotizing beats.

Mutabaruka & Nicky Z curated the evening’s events, adding a level of soul and purpose to what has been an incredibly spiritual and historic endeavor so far. Doctors were on-site offering free medicals, qualifying guests for their medical marijuana cards. The climax of the night: the ribbon cutting ceremony signifying the end of one long journey and the beginning of another for both the McKenzie brothers and medical marijuana in Jamaica.

As the first company to be granted a license to cultivate and then subsequently received licenses to process and retail medical grade ganja by the CLA (Cannabis Licensing Authority) in Jamaica, EPICAN is proud to offer a quality product rooted in Jamaican sun and soil. The McKenzie brothers have spent three years educating local farmers in methods that meet international growing standards in an effort to bring marijuana farming out of the shadows in Jamaica and onto the bright light of a global stage.

In addition to EPICAN’s to a 43,000-square foot vertically integrated cultivation facility, they also have a 5,000-square foot, state-of-the-art extraction plant that is able to process and support its own organic cultivation output. This first-world facility focuses solely on cannabinoid and terpene extraction, identification and formulation for medical purposes within our Jamaican market. This ensures that EPICAN can continue to turn out a consistent product that is of the highest quality, potency and purity.

“It’s not about getting high,” says Dwayne McKenzie, President of EPICAN, “In Jamaica, cannabis will be produced by licensed producers and distributed to aid persons – It’s about the therapeutic proponents of the cannabis plant ”

Marijuana’s healing properties are attributed to its high cannabidiol (CBD) content and critical levels of medical terpenes and flavonoids. EPICAN intends to deliver these healing properties in the form of topical treatments, oils and raw strains of the plant itself, all for sale now at their Marketplace location. The McKenzie brothers and their partner Neil Taylor have the utmost respect and love for the marijuana plant, believing that it is a vehicle of limitless healing for those in need.

EPICAN currently employs over 50 local farmers at its growing facility in the Blue Mountains. They started CanEx, Jamaica’s first Cannabis conference so ideas and information could be exchanged between interested parties. EPICAN has been working to educate the public on the healing benefits of cannabis through their sponsorship of Rebel Salute’s Herb Curb, staying true to their tagline of: educate, medicate, elevate.

“Our long-term national strategic interest is to ensure the competitiveness of Jamaica’s marijuana industry,” says Karibe McKenzie, CEO when asked about Jamaica’s place in the increasing competitive global marijuana market. Since 2015, EPICAN has been studying and identifying indigenous Jamaican strains of cannabis as well as analyzing the ratios of cannabinoids and terpene profiles within those plants in conjunction with Jamaica’s Scientific Research Council (SRC), in an effort to pinpoint what makes Jamaican cannabis unique.

One day the Jamaican Blue Mountains will be known not only for its world-class coffee but hopefully also it’s world-class cannabis. EPICAN’s doors are now open for business in Marketplace. Come by to get educated, medicated and elevated today!

Tara Scott
Street Smarts
8769970383
email us here


Source: EIN Presswire

Co-Diagnostics Announces Submission of CE Mark Registration for Tuberculosis Screening Test

Company’s Logix Smart™ MTB Test to be available for purchase with CE mark in August 2018

LONDON, UNITED KINGDOM, July 17, 2018 /EINPresswire.com/ — Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests, announced today that its Logix Smart™ MTB Test technical file has been submitted for registration with the European Community, and that the CE marked in vitro diagnostic (“IVD”) is expected to be available for purchase early in August in markets that accept a CE mark as valid regulatory approval.

The technical file dossier and CE marking confirms that the test meets the Essential Requirements of the European Community’s In-Vitro Diagnostic Medical Device Directive (IVDD 98/79/EC). The registration process is expected to be complete by the end of July, at which point sales of the product may commence as an IVD with the CE marking included. The Logix Smart MTB Test detects DNA of mycobacteria tuberculosis (MTB) complex members and functions via real-time polymerase chain reaction (PCR) to detect and amplify the IS6110 and MPB64 regions of the MTB genome.

The newest iteration of their MTB screening test has been tailored to target detection of the two genes present in a broad range of tuberculosis infections, to greatly mitigate the potential of false negatives and improve the diagnosis and prognosis of patients afflicted with this disease worldwide. It is built on Co-Diagnostics’ proprietary CoPrimer™ design platform to virtually eliminate “primer-dimers,” the often-occurring phenomenon that leads to false positives in these types of diagnostics.

The key component to battling tuberculosis is an early, accurate, and affordable diagnosis. The Company believes that this will help them to better meet the global demand for detection of a disease with 99.9% of infections occurring outside of the United States, and that causes over 1.5 million deaths per year. Roughly 95% of these deaths occur in low and middle-income countries, which includes those in Eastern Europe in addition to many across Central America and the Caribbean basin. In the case of the latter, the Departments or Ministries of Health recognize clearance by the European Community as valid regulatory approval to allow sale of CE marked products throughout their jurisdictions.
Click here to read more about Co-Diagnostics.

This Press Release has been prepared by the Healthcare Trends Team of The Wall Street Club.

Forward-Looking Statements:
This press release contains forward-looking statements. Forward-looking statements can be identified by words such as "believes," "expects," "estimates," "intends," "may," "plans," "will" and similar expressions, or the negative of these words. Such forward-looking statements are based on facts and conditions as they exist at the time such statements are made and predictions as to future facts and conditions. Readers of this press release are cautioned not to place undue reliance on any forward-looking statements. The Company and The Wall Street Club undertake no obligation to update any forward-looking statement relating to matters discussed in this press release, except as may be required by applicable securities laws.

European Office
BDA International Investor Relations
+34 932688282
email us here


Source: EIN Presswire

Community Oncology Alliance Submits Formal Comments on President’s Blueprint to Reduce Drug Prices

Applauds Administration for Taking Bold Action to Address High Drug Prices, Cautions Against Misguided Policy Changes That Would Negatively Impact Patients

We commend the Trump Administration for taking on the tremendous challenge of reducing drug costs in America.”

— Jeff Vacirca, MD, president of COA and CEO of NY Cancer Specialists

WASHINGTON, DISTRICT OF COLUMBIA, UNITED STATES, July 17, 2018 /EINPresswire.com/ — The Community Oncology Alliance (COA) formally submitted comments to the Health and Human Services (HHS) Secretary Alex Azar regarding President Trump’s “Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.”

In the comment letter, COA provides HHS with specific data and history driven input on the blueprint’s numerous policy proposals. Because of community oncology’s long-standing commitment to oncology payment and system reform, the letter includes significant real-world insight into the impact that the proposals would have if implemented, as demonstrated by the current treatment experiences of patients with cancer. The letter also provides HHS numerous detailed solutions aimed at ensuring the affordability of and access to life-saving cancer treatments.

“We commend the Trump Administration for taking on the tremendous challenge of reducing drug costs in America. Continuously increasing drug prices and cancer care costs are unsustainable and unacceptable, and we must act together to do something about it. No one knows this better than the men and women of community oncology who are on the frontlines of America’s cancer care system,” said Jeff Vacirca, MD, president of COA and CEO of NY Cancer Specialists.

In the letter COA warns the administration that it is important to focus on the true drivers of health care spending and to avoid new policies that would result in unintended consequences for patients, their families, and their care teams. This includes specific blueprint proposals such as the shift of cancer drugs from Part B to Medicare Part D; increases in the roles, leverage, and power of third party middlemen, such as Pharmacy Benefit Managers (PBMs); or further increasing formulary flexibility for Part D plans. History has shown that even well-intended policymaking can backfire, decreasing patient access to treatment, increasing their costs, and compromising the viability of community oncology cancer care without generating the desired Medicare savings.

Read the full letter at http://bit.ly/coablueprintcomments

Nicolas Ferreyros
Community Oncology Alliance
2027298147
email us here


Source: EIN Presswire

Trish Martin of Neuroplasticity & Education United to be Featured on CUTV News Radio

JENISON, MICHIGAN, UNITED STATES, July 17, 2018 /EINPresswire.com/ — Our democracy depends on literacy. We need a literate society to be able to make informed decisions. But according to recent national statistics, the current reading proficiency score for fourth graders is 32 percent.

Trish Martin is the founder of Neuroplasticity & Education United, where she works with school districts across the country, training teachers how to teach reading by unlocking the power of neuroplasticity.

“We try to make reading as addictive as a video game,” says Martin. “When kids come to us entering kindergarten, they come wanting to learn.”

After 25 years as a speech pathologist, Martin has spent the last 14 years teaching and promoting the fundamental building blocks of literacy through a revolutionary, scientifically and evidence-based instructional series. She developed the “Neuroplasticity: Rewiring the Brain” series and has authored multiple instructional curriculum books, student workbooks along with extensive support materials and instructional videos. She is now expanding to provide parents the support materials they need to help their child get to the next level.

The English language has 44 sounds and approximately 256 ways to spell them. English has four layers: Anglo-Saxon, Latin, Greek and French. Once we get to fourth grade, the words the child is being asked to read will be 60 percent Latin or Greek in origin.

“The educational system at the university level rarely teaches the subtler aspects of how the language goes together, or how to actually teach a child to read,” says Martin. “We have not provided the necessary instruction to the child for them to be able to read to their potential.”

“If I were to send my granddaughter to a piano teacher, the first thing the piano teacher would do is teach the keys of the piano. So if I'm going to be an elementary teacher, I should probably know how many sounds there are in the English language that I need to teach and understand that words are built by linking syllables together.”

Of course, teachers face many challenges. The brain is a use-it-or-lose-it system; whatever neurological pathways are used the most will build the strongest highways. Children today are spending approximately four hours each day in front of a visual screen. This in turn builds powerful visual roads in the brain. Unfortunately children spend significantly less time than children in prior generations processing oral language and developing their auditory system. They are also spending less time stimulating their imagination which also requires language.

“They have weak roads in the brain,” says Martin. “Once you understand where things live in the brain, you can figure out how to design a task to build that road. We have to train teachers how to do that. You can use any content you want. I use literacy.”

Martin says unlocking the reading code is not just about the children that struggle.

“I have spent years fine-tuning these lessons, so any teacher or parent is capable of improving their child's capacity to read,” says Martin. “Every child benefit, and your high-end reader just explodes.”

CUTV News Radio will feature Trish Martin in an interview with Jim Masters on July 19th and July 26th at 11am EDT.

Listen to the show on BlogTalkRadio. If you have a question for our guest, call (347) 996-3389.

For more information, visit http://www.neued.org

Lou Ceparano
CUTV News
(631) 850-3314
email us here


Source: EIN Presswire

Charles Laverty Supporting SCOTUS Nominee Brett Kavanaugh’s as Good For Small Business

Charles Laverty  Supports Supreme Court Nominess Brett Kavanaugh. Will Be good for business

Charles Laverty Says Brett Kavanaugh Will Be good for business

Charles Laverty from Los Angeles, CA

CEO Charles Laverty from Los Angeles, CA

Healthcare CEO and commentator Charles Laverty joined many in the business community in backing President Trump's SCOTUS nominee.

Kavanaugh overturned harmful regulations 75 times. That is good for medical device companies like ABS and the small business who are critical for jobs and economic growth.”

— Charles Laverty

NEWPORT BEACH, CALIFORNIA, UNITED STATES, July 17, 2018 /EINPresswire.com/ — Healthcare CEO, Charles Laverty, writing in a USA Herald Op-Ed announced his support of President Trump’s nomination of Brett Kavanaugh to the Supreme Court. ABS is a medical device company with a record of consistent innovation, backed by strong patent protection. The company is in the advanced stages of development on a ground-breaking new stenting technology that will simplify heart surgery and save lives.

Charles Laverty believes that Kavanaugh is the right choice for the Supreme Court because he has consistently opposed over regulation in favor of greater freedom and innovation. Medical companies such as ABS are always faced with regulatory hurdles and these are mostly justified. Supreme Court judges that are against unnecessary regulation help to ensure the ones in place are fair and consistent with American law.

Charles Laverty, whose company, is developing products that he hopes could save lives, notes that Kavanaugh has ruled against regulations that violated American law on 75 separate occasions. He believes that he will continue this approach if successfully appointed to the Supreme Court. That’s a positive development for medical device companies like ABS and small business ventures across all categories.

The 53-year-old Kavanaugh has the experience needed to be successful on the Supreme Court. He’s spent several years as a federal appeals court judge in the District of Columbia. In that time he’s played a role in many important judgements that have had consequences for all Americans. Laverty believes his judgements have been consistently fair and impartial and that’s why he’s backing Kavanaugh’s nomination to the Supreme Court.

ABS is a company built on medical innovation and there stenting technology can improve the lives of millions of Americans. Charles Laverty says that regulations that prevent medical innovators from bringing this type of technology to the public need to be avoided. President Trumps latest nomination to the Supreme Court will help to ensure over regulation doesn’t hamper companies like this.

Charles Laverty previously announced major expansion plans for ABS in 2018. Charles Laverty serves as chief executive of Advanced Bifurcation Systems. ABS is a clinical stage medical device company in the advanced stages of development of an innovative new medical stenting technology. This new methodology simplifies the process of stenting bifurcation lesions and it will replace complicated procedures with day surgery for many patients. Their approach will eliminate the need for open-heart surgery in the majority of cases. Charles Laverty is the CEO of ABS and a strong advocate of innovation and deregulation.

Charles Laverty
Advanced Bifurcation Systems
(949)432-4824
email us here


Source: EIN Presswire

New grant offering signals increased role for infectious diseases specialists researching Alzheimer’s causation

Dr. Leslie Norins, an Emeritus member of the Infectious Diseases Society of America, is funding two grants to help researchers explore germs in Alzheimer's.

Despite many clues suggesting infectious agents might be triggering Alzheimer’s disease, until now there have been too few infectious disease experts involved in researching this possibility.”

— Dr. Leslie Norins

NAPLES, FL, UNITED STATES, July 17, 2018 /EINPresswire.com/ — The recently announced offering of two research grants by the Infectious Diseases Society of America Foundation signals the timely addition of a relevant medical specialty to those already seeking the causes of Alzheimer’s disease (AD), says Leslie Norins, MD, PhD, founder and CEO of Alzheimer’s Germ Quest Inc.

“This is the first time a major group of infectious disease experts feels it is worthwhile to examine the possibility of infection as a root cause of AD,” he says.

Dr. Norins predicts ripple effects far beyond the relatively small dollar amounts offered in these initial “seed research” offerings—$50,000 each—due to the stature of the group involved. The Foundation is the research and education arm of the Infectious Diseases Society of America (IDSA).

“With the recent evidence further implicating herpes virus as a possible trigger for AD, and the new concept that the amyloid plaques and tangles in the afflicted brain may represent the body’s immune reaction to infectious agents, there is no more pertinent specialty than infectious diseases to help extend these beachheads,” he says.
IDSA is the principal U.S. organization for specialists in infectious diseases, Dr. Norins says, and among other activities provides board certification. It has over 11,000 members. He is an emeritus fellow of the group.

Dr. Norins adds, “Despite many clues suggesting infectious agents might be triggering Alzheimer’s disease, until now there have been too few infectious disease experts involved in researching this possibility.” He attributes this lack of prior involvement to the paucity of research funds allocated by government and advocacy group funders for worthwhile investigations on infectious possibilities. “Most of the billions of dollars in AD grant money for years has been reserved for the more traditional studies of amyloid plaques and protein tangles. Now research on germ involvement must get a fair share,” he says.

The grants were made possible by a donation to the Foundation by Dr. Norins and his wife Rainey Norins. Grant applications can be obtained from foundation@idsociety.org.

Alzheimer’s Germ Quest, Inc. is a public benefit corporation headquartered in Naples Florida. Its mission is to accelerate and deepen scientific investigations into the possible role of infectious agents as the root cause of Alzheimer’s disease. It is the sponsor of the $1 Million Alzheimer’s Germ Quest Challenge Award for scientists. (ALZgerm.org).

Mollie Page Griffin
Alzheimer's Germ Quest
2397777243
email us here


Source: EIN Presswire

Vantage Agora Launches New Digital Signage Tool, OX Media

OX Media is the latest and greatest digital signage tool on the OX Zion platform.

OX Media is the latest and greatest digital signage tool on the OX Zion platform.

With real-time data, user-friendly drag-and-drop design and gorgeous graphics, Vantage Agora's new digital signage tool helps you manage your message.

What sets us apart is that OX Zion’s APIs and Data Extraction tools can pull data from different systems such as POS, Financial, CRM systems and display this information on digital signage.”

— Mehul Kenia, Vantage Agora Product Architect

CLEVELAND, OHIO, UNITED STATES, July 17, 2018 /EINPresswire.com/ — CLEVELAND, July 17, 2018 — Vantage Agora, the leading expert in Operational Excellence for businesses of all sectors, is proud to announce the launch of OX Media, the newest feature of its Business Operating System (BOS), OX Zion.

OX Media is a signage feature integrated with OX Zion that allows you to create, display, and manage internal and external communications. You’ll now be able to control the information you digitally display on monitors of all sizes to your customers, prospects, and employees – anytime, anywhere – all from the cloud.

Using OX Media, you can set up multiple locations, create location-specific playlists, and assign numerous devices to the playlists you create. Take advantage of drag-and-drop functionality to broadcast whatever you choose to display on-screen, including video, HTML pages and widgets.

Vantage Agora’s patented ‘No-Developer-Needed’ technology (NDN) also makes advanced content editing via OX Media simple and intuitive. Additionally, businesses can track and display both internal and external data in real-time, including social media mentions, top performing employees and even details as specific as customer wait times.

Mehul Kenia, Vantage Agora’s Product Architect states, “What sets us apart is that OX Zion’s APIs and Data Extraction tools can pull data from different systems such as POS, Financial, CRM systems and display this information on digital signage.” Whatever the industry, OX Media offers an expansive, user-friendly asset that helps you display your message to the world effectively and efficiently.

About Vantage Agora

Vantage Agora is a Beachwood, Ohio-based team with expertise in operations, technology, Six Sigma, lean management, business process re-engineering (BPR) and business process management (BPM), focused on helping clients reduce operational costs, improve quality and boost revenues. Vantage Agora also offers a dynamic Business Operating System, OX Zion, launched in 2015. For information, news and events, visit www.vantageagora.com.

Allison Shumaker
Vantage Agora
888.246.7211 x 107
email us here


Source: EIN Presswire